NutriBand EPS NTRB
Diluted earnings per share by quarter and over the last twelve months, from 2016.
- Last 12 months, to Jul 31, 2026
- −$0.57
- Latest quarter, Q2 FY27
- −$0.07
- Fiscal year 2026
- −$2.64
NutriBand's earnings per share was −$0.57 over the twelve months to Jul 31, 2026.
In its latest quarter, Q2 FY27, it was −$0.07.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$2.64 | n/a |
| FY2025 | −$0.98 | n/a |
| FY2024 | −$0.69 | n/a |
| FY2023 | −$0.55 | n/a |
| FY2022 | −$0.83 | n/a |
| FY2021 | −$0.49 | n/a |
| FY2020 | −$0.49 | n/a |
| FY2019 | −$0.62 | n/a |
| FY2018 | −$0.44 | n/a |
| FY2017 | $0.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY27 | −$0.07 | n/a | −$0.57 | |
| Q1 FY27 | −$0.10 | n/a | −$2.62 | |
| Q4 FY26 | −$0.08 | n/a | −$2.64 | |
| Q3 FY26 | −$0.32 | n/a | −$3.06 | |
| Q2 FY26 | −$2.12 | n/a | −$2.86 | |
| Q1 FY26 | −$0.12 | n/a | −$0.89 | |
| Q4 FY25 | −$0.50 | n/a | −$0.98 | |
| Q3 FY25 | −$0.12 | n/a | −$0.71 | |
| Q2 FY25 | −$0.15 | n/a | −$0.81 | |
| Q1 FY25 | −$0.21 | n/a | −$0.77 | |
| Q4 FY24 | −$0.23 | n/a | −$0.69 | |
| Q3 FY24 | −$0.22 | n/a | −$0.67 |
Against its peers
Companies in Medical - Instruments & Supplies nearest NutriBand's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| NTRBNutriBand | −$0.57 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| NEPHNephros | $0.16 | +33% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| Peer median | $1.08 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on NutriBand
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.